Successful treatment of acute pancreatitis associated with late-onset acute liver GVHD after second allogeneic hematopoietic cell transplantation.

acute graft-versus-host disease (GVHD) acute pancreatitis corticosteroids tacrolimus

Journal

Blood cell therapy
ISSN: 2432-7026
Titre abrégé: Blood Cell Ther
Pays: Japan
ID NLM: 9918333884906676

Informations de publication

Date de publication:
25 Aug 2022
Historique:
received: 01 11 2021
accepted: 14 02 2022
entrez: 30 1 2023
pubmed: 31 1 2023
medline: 31 1 2023
Statut: epublish

Résumé

We report the case of a 28-year-old woman who developed upper abdominal pain and jaundice after a second unrelated allogeneic hematopoietic cell transplantation (allo-HCT) for acute lymphoid leukemia (ALL). Laboratory data showed elevated levels of liver enzymes, amylase, and lipase. Although acute pancreatitis was suspected, no structural lesions were detected. Liver biopsy was compatible with late-onset acute graft-versus-host disease (GVHD), which resolved following treatment with methylprednisolone (mPSL) and tacrolimus (TAC). In addition, her serum amylase level and abdominal pain rapidly resolved following acute GVHD-directed therapy. Acute pancreatitis concomitant with late-onset acute liver GVHD is extremely rare and has not been documented subsequent to a second allo-HCT.

Identifiants

pubmed: 36712552
doi: 10.31547/bct-2021-023
pmc: PMC9873419
doi:

Types de publication

Case Reports

Langues

eng

Pagination

79-82

Informations de copyright

Copyright Ⓒ2022 Asia-Pacific Blood and Marrow Transplantation Group (APBMT).

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. Disclosure forms provided by the authors are available on the website.

Références

Blood. 2009 Jul 16;114(3):702-8
pubmed: 19470693
Gastroenterol Clin Biol. 2008 Apr;32(4):413-6
pubmed: 18378104
Dig Dis Sci. 1999 Jun;44(6):1124-7
pubmed: 10389682
J Gastrointest Oncol. 2016 Apr;7(Suppl 1):S21-31
pubmed: 27034810
Biol Blood Marrow Transplant. 2020 Jun;26(6):1171-1178
pubmed: 31874219
Int J Hematol. 2021 Oct;114(4):494-501
pubmed: 34291421
Blood. 2020 Jul 23;136(4):429-440
pubmed: 32526035
N Engl J Med. 2012 Oct 18;367(16):1487-96
pubmed: 23075175
Bone Marrow Transplant. 1997 Dec;20(12):1081-6
pubmed: 9466282
BMJ Case Rep. 2016 Aug 02;2016:
pubmed: 27485875
Bone Marrow Transplant. 2001 Jan;27(2):163-6
pubmed: 11281385
Br J Haematol. 2019 Sep;186(5):767-776
pubmed: 31115916
Bone Marrow Transplant. 2000 Jul;26(1):109-11
pubmed: 10918414

Auteurs

Yuka Hosokawa (Y)

Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.

Tomomi Toubai (T)

Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.

Rintaro Ohe (R)

Department of Pathology, Yamagata University Faculty of Medicine, Yamagata, Japan.

Masashi Hosokawa (M)

Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.

Ryo Sato (R)

Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.

Akane Yamada (A)

Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.

Keiko Aizawa (K)

Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.

Masahito Himuro (M)

Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.

Satoshi Ito (S)

Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.

Masakazu Yamamoto (M)

Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.

Daniel Peltier (D)

Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.

Kenichi Ishizawa (K)

Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.

Classifications MeSH